Dr. Stacy D’Andre is a board-certified internal medicine specialist and oncologist with expertise in treating elderly patients with gastrointestinal (GI) and gynecologic cancers. In addition to patient care, Dr. D’Andre leads treatment advances through her research into new therapies and optimal management of colorectal, pancreatic, endometrial and other types of cancer. She is a Principal Investigator for National Cancer Institute-sponsored oncology group clinical trials including GOG (Gynecologic Oncology Group) and NSABP (National Surgical Adjuvant Breast and Bowel Project), as well as for industry-sponsored clinical trials supported by the Sutter Institute for Medical Research (SIMR). Dr. D’Andre serves as Executive Chair of the Sutter Cancer Research Consortium as well as Medical Director at Sutter Cancer Center. She has authored numerous publications, book chapters and abstracts on emerging treatment options for gynecologic and GI cancers.
Sutter Health Research Enterprise
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 453-3300
simr@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Novocure LUNAR
Effect of Tumor Treating Fields Concurrent W/ Standard of Care Therapies for Treatment of Stage 4 NSCLC following Platinum Failure (LUNAR)
Investigators: Deepti Behl MD, Stacy D'Andre MD, Nitin Rohatgi MD, Melissa Williams M.D.
Status: Active, Not Recruiting
Publications
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study.
5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study.
Oxalate transport in cultured porcine renal epithelial cells.
Oxalate transport in cultured porcine renal epithelial cells.